NCT07081841Enrolling By Invitation不适用
Long-Term Safety and Efficacy Follow-up of AB-1005 Gene Transfer Study Participants With Parkinson's Disease or Multiple System Atrophy
AskBio Inc2 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2025年9月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 132
- 试验地点
- 2
- 主要终点
- Long term safety and tolerability
研究概览
简要总结
This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PD and MSA-P participants that are or were enrolled in an interventional AB-1005 study and provide informed consent
排除标准
- •There are no exclusion criteria
结局指标
主要结局
Long term safety and tolerability
时间窗: Up to 10 years post surgery
Measure of the occurrence of serious and non-serious adverse events
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
终止
不适用
Long Term Follow-Up Study for rAAV-GAD Treated SubjectsParkinson's DiseaseNCT01301573Neurologix, Inc.40
终止
不适用
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)Parkinson's DiseaseNCT00804479University of Rochester222
Unknown
不适用
A Longitudinal Study in Parkinson's Disease (PD) PatientsParkinson's DiseaseNCT01730599Tel-Aviv Sourasky Medical Center200
Enrolling By Invitation
不适用
Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01Parkinson DiseaseNCT05897957BlueRock Therapeutics12
已完成
2 期
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease PatientsParkinson's DiseaseNCT01628965Otsuka Pharmaceutical Co., Ltd.143